{"id":"https://openalex.org/W2508779196","doi":"https://doi.org/10.15761/cogrm.1000117","title":"A Phase II trial of intravenous bevacizumab, paclitaxel and intraperitoneal cisplatin followed by intravenous bevacizumab maintenance for treatment of stage II-III ovarian cancer","display_name":"A Phase II trial of intravenous bevacizumab, paclitaxel and intraperitoneal cisplatin followed by intravenous bevacizumab maintenance for treatment of stage II-III ovarian cancer","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2508779196","doi":"https://doi.org/10.15761/cogrm.1000117","mag":"2508779196"},"language":"en","primary_location":{"id":"doi:10.15761/cogrm.1000117","doi":"https://doi.org/10.15761/cogrm.1000117","is_oa":true,"landing_page_url":"https://doi.org/10.15761/cogrm.1000117","pdf_url":"https://www.oatext.com/pdf/COGRM-1-117.pdf","source":{"id":"https://openalex.org/S4210199558","display_name":"Clinical Obstetrics Gynecology and Reproductive Medicine","issn_l":"2059-4828","issn":["2059-4828"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Obstetrics, Gynecology and Reproductive Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.oatext.com/pdf/COGRM-1-117.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021715275","display_name":"Grainger S. Lanneau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296080982","display_name":"Naval Medical Center San Diego","ror":"https://ror.org/02n14ez29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1296080982","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grainger L. Lanneau","raw_affiliation_strings":["Naval Medical Center, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Naval Medical Center, San Diego, CA, USA","institution_ids":["https://openalex.org/I1296080982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110045760","display_name":"LaToya J. Perry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162219","display_name":"Quincy Medical Center","ror":"https://ror.org/034ekjs90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"LaToya J. Perry","raw_affiliation_strings":["Cadence Physician Group , Winfield , IL , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cadence Physician Group , Winfield , IL , USA","institution_ids":["https://openalex.org/I4210162219"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069337573","display_name":"Kathleen N. Moore","orcid":"https://orcid.org/0000-0002-5803-0718","observed_orcids":["https://orcid.org/0000-0002-5803-0718"]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]},{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kathleen N. Moore","raw_affiliation_strings":["Stephenson Oklahoma Cancer Center at the University of Oklahoma. Oklahoma City, OK, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stephenson Oklahoma Cancer Center at the University of Oklahoma. Oklahoma City, OK, USA","institution_ids":["https://openalex.org/I4390039380","https://openalex.org/I8692664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111784025","display_name":"J. Curiel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]},{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Curiel RN","raw_affiliation_strings":["Stephenson Oklahoma Cancer Center at the University of Oklahoma. Oklahoma City, OK, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stephenson Oklahoma Cancer Center at the University of Oklahoma. Oklahoma City, OK, USA","institution_ids":["https://openalex.org/I4390039380","https://openalex.org/I8692664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021105630","display_name":"Michael A. Gold","orcid":"https://orcid.org/0000-0002-6804-9850","observed_orcids":["https://orcid.org/0000-0002-6804-9850"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A. Gold","raw_affiliation_strings":["Tulsa Cancer Institute , Tulsa OK , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tulsa Cancer Institute , Tulsa OK , USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061736280","display_name":"Robert S. Mannel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]},{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert S. Mannel","raw_affiliation_strings":["Stephenson Oklahoma Cancer Center , 800 NE 10 th St Oklahoma City , Oklahoma 73121 , USA,","Stephenson Oklahoma Cancer Center at the University of Oklahoma. Oklahoma City, OK, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stephenson Oklahoma Cancer Center , 800 NE 10 th St Oklahoma City , Oklahoma 73121 , USA,","institution_ids":["https://openalex.org/I4390039380"]},{"raw_affiliation_string":"Stephenson Oklahoma Cancer Center at the University of Oklahoma. Oklahoma City, OK, USA","institution_ids":["https://openalex.org/I4390039380","https://openalex.org/I8692664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053990407","display_name":"Joan L. Walker","orcid":"https://orcid.org/0000-0002-5034-4309","observed_orcids":["https://orcid.org/0000-0002-5034-4309"]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]},{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joan L. Walker","raw_affiliation_strings":["Stephenson Oklahoma Cancer Center at the University of Oklahoma. Oklahoma City, OK, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stephenson Oklahoma Cancer Center at the University of Oklahoma. Oklahoma City, OK, USA","institution_ids":["https://openalex.org/I4390039380","https://openalex.org/I8692664"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108555243","display_name":"Donald Scott McMeekin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]},{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Scott McMeekin","raw_affiliation_strings":["Stephenson Oklahoma Cancer Center at the University of Oklahoma. Oklahoma City, OK, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stephenson Oklahoma Cancer Center at the University of Oklahoma. Oklahoma City, OK, USA","institution_ids":["https://openalex.org/I4390039380","https://openalex.org/I8692664"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5069337573"],"corresponding_institution_ids":["https://openalex.org/I4390039380","https://openalex.org/I8692664"],"apc_list":null,"apc_paid":null,"fwci":0.3809,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.74399285,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"1","issue":"3","first_page":"60","last_page":"65"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.8320000171661377},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8579999804496765},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8830000162124634},{"id":"https://openalex.org/keywords/intraperitoneal-cisplatin","display_name":"intraperitoneal cisplatin","score":0.9390000104904175},{"id":"https://openalex.org/keywords/intraperitoneal-chemotherapy","display_name":"intraperitoneal chemotherapy","score":0.9449999928474426},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7170000076293945},{"id":"https://openalex.org/keywords/neuropathy","display_name":"neuropathy","score":0.7250000238418579},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8299999833106995},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.7319999933242798},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9350000023841858},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9160000085830688}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.9286167621612549},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.8001967668533325},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7536972761154175},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7413609027862549},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7067105770111084},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4192601442337036},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.38864612579345703},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3073781132698059},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2925402522087097}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.15761/cogrm.1000117","doi":"https://doi.org/10.15761/cogrm.1000117","is_oa":true,"landing_page_url":"https://doi.org/10.15761/cogrm.1000117","pdf_url":"https://www.oatext.com/pdf/COGRM-1-117.pdf","source":{"id":"https://openalex.org/S4210199558","display_name":"Clinical Obstetrics Gynecology and Reproductive Medicine","issn_l":"2059-4828","issn":["2059-4828"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Obstetrics, Gynecology and Reproductive Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.15761/cogrm.1000117","doi":"https://doi.org/10.15761/cogrm.1000117","is_oa":true,"landing_page_url":"https://doi.org/10.15761/cogrm.1000117","pdf_url":"https://www.oatext.com/pdf/COGRM-1-117.pdf","source":{"id":"https://openalex.org/S4210199558","display_name":"Clinical Obstetrics Gynecology and Reproductive Medicine","issn_l":"2059-4828","issn":["2059-4828"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Obstetrics, Gynecology and Reproductive Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2508779196.pdf","grobid_xml":"https://content.openalex.org/works/W2508779196.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W128774778","https://openalex.org/W1758230404","https://openalex.org/W1922469696","https://openalex.org/W1970672025","https://openalex.org/W1973753485","https://openalex.org/W1999123521","https://openalex.org/W2018929154","https://openalex.org/W2022157561","https://openalex.org/W2076494316","https://openalex.org/W2076941933","https://openalex.org/W2096521047","https://openalex.org/W2101476680","https://openalex.org/W2104980227","https://openalex.org/W2105651363","https://openalex.org/W2107402595","https://openalex.org/W2152574852","https://openalex.org/W2316501478","https://openalex.org/W2317367307","https://openalex.org/W2320618121","https://openalex.org/W2323421427","https://openalex.org/W2334228902","https://openalex.org/W2753398179","https://openalex.org/W4247636691"],"related_works":["https://openalex.org/W2107402595","https://openalex.org/W2263037777","https://openalex.org/W2061618384","https://openalex.org/W4237324201","https://openalex.org/W2225002082","https://openalex.org/W2912004757","https://openalex.org/W2937594202","https://openalex.org/W2416520496","https://openalex.org/W1985382542","https://openalex.org/W2055390649"],"abstract_inverted_index":{"Objective:":[0],"Acceptance":[1],"of":[2,18,64,146,151,157,194,228],"intraperitoneal":[3],"(IP)":[4],"chemotherapy":[5],"has":[6],"not":[7],"been":[8],"widespread":[9],"with":[10,26,43,133,139,175],"anticipated":[11],"toxicity":[12],"commonly":[13],"cited":[14],"as":[15,60,62],"a":[16,22,191,212,235],"limitation":[17],"this":[19],"therapy.We":[20],"evaluated":[21],"modified":[23,213],"IP":[24,89,147,214,231,245],"regimen":[25,215],"IV":[27,68,74,103,209],"bevacizumab":[28,75,104,210],"to":[29,49,57,119,211,219],"determine":[30],"feasibility":[31,59],"and":[32,73,137,149,168,184,200,204,226],"assess":[33],"toxicities.Methods:":[34],"A":[35],"phase":[36],"II":[37],"study":[38],"was":[39,56,117,173],"conducted":[40],"in":[41,244],"patients":[42,101,128,186],"advanced":[44],"ovarian":[45],"cancer":[46],"following":[47],"cytoreduction":[48],"<":[50],"1cm":[51],"residual":[52],"disease.The":[53],"primary":[54,99],"aim":[55],"evaluate":[58],"defined":[61],"completion":[63,237],"6":[65,97,144],"cycles.Patients":[66],"received":[67,102,143,153],"paclitaxel":[69,232],"135":[70],"mg/m":[71,87],"2":[72,88],"15":[76,105],"mg/kg":[77,106],"(cycle":[78],"2-6)":[79],"on":[80],"day":[81,90,229],"1":[82],"followed":[83],"by":[84,170],"cisplatin":[85,224,247],"75":[86],"2,":[91],"repeated":[92],"every":[93],"21":[94],"days":[95,109],"x":[96,110],"cycles.Following":[98],"therapy,":[100],"maintenance":[107],"q21":[108],"12":[111,155],"cycles.The":[112],"FACT":[113],"GOG":[114,220],"NTX":[115],"tool":[116],"used":[118],"prospectively":[120],"monitor":[121],"neuropathy":[122,160,240],"scores":[123],"over":[124],"treatment.Results:":[125],"20":[126],"evaluable":[127],"are":[129],"presented":[130],"including":[131],"85%":[132],"stage":[134],"III":[135],"disease,":[136],"75%":[138],"no":[140],"gross":[141],"residual.85%":[142],"cycles":[145,156],"therapy":[148],"77%":[150],"these":[152],"all":[154],"maintenance.Scores":[158],"for":[159],"worsened":[161],"through":[162],"cycle":[163],"6,":[164],"peaked":[165],"at":[166],"9":[167],"improved":[169],"18.":[171],"Toxicity":[172],"acceptable":[174],"neutropenia":[176],"the":[177,197,222],"most":[178],"common":[179],"grade":[180,188],"3-4":[181],"adverse":[182],"event,":[183],"8":[185,230],"experienced":[187],"2-3":[189],"neuropathy.With":[190],"median":[192,198],"follow-up":[193],"63":[195],"months,":[196],"PFS":[199],"OS":[201],"is":[202,216],"50":[203],"71":[205],"months":[206],"respectively.Conclusions:":[207],"Adding":[208],"feasible.As":[217],"compared":[218],"172,":[221],"lower":[223],"dose":[225],"omission":[227],"may":[233],"allow":[234],"higher":[236],"rate.Despite":[238],"modifications,":[239],"remains":[241],"important":[242],"issue":[243],"based":[246],"regimens.":[248]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-09-16T00:00:00"}